Bank Venture Debt vs Non-Bank Funds: Cost vs Flexibility

Bank venture debt groups typically price lower than non-bank funds, but that pricing usually comes with strings: an expectation that you'll move your operating deposits to that bank, sometimes a requirement written directly into the loan agreement, and generally more conservative underwriting that can mean a smaller facility or stricter covenants than a non-bank lender might offer for the same company. Banks are also more sensitive to broader credit conditions, since they're managing a regulated balance sheet, which can show up as tighter underwriting standards during periods when credit markets generally get more cautious.

Non-bank venture debt funds aren't bound by the same regulatory capital requirements or deposit relationship expectations, which gives them more room to underwrite earlier-stage or higher-risk companies that a bank would decline. That flexibility comes at a cost: higher interest rates, often more warrant coverage, and sometimes more aggressive covenant packages, since the fund is taking on more risk and pricing accordingly rather than relying on a broader banking relationship to make the economics work.

Non-bank funds are often able to move faster through underwriting and closing, since they're not subject to the same internal committee processes and regulatory considerations a bank's credit approval involves. If timing matters more than getting the absolute lowest rate, a non-bank fund is frequently able to close in less time than a bank lending group, particularly for a company that doesn't fit neatly into a bank's standard underwriting profile.

That flexibility can also show up in how a non-bank fund structures the deal itself, such as sizing against ARR rather than requiring the tangible collateral or profitability metrics a bank's standard underwriting box expects. If your company's story doesn't fit a conventional lending narrative, that willingness to structure around your specific situation is often worth more than a lower headline rate would have been.

Banks typically ask for smaller warrant coverage, if any, since their return comes primarily from interest income on a relationship they hope to expand over time. Non-bank funds usually build a larger warrant component into the deal, treating it as meaningful compensation for the additional risk they're taking on at a rate a bank wouldn't accept. When comparing term sheets from each type of lender, weigh the warrant coverage alongside the interest rate, not as an afterthought, since it represents real future dilution regardless of how the headline rate compares.

A company with predictable cash flow, an established banking relationship, and a profile that fits conservative underwriting is usually better served starting with a bank lending group, where the pricing is more favorable. A company earlier in its growth, without a clean fit for bank underwriting, or needing to close on a tighter timeline, often has no realistic option beyond a non-bank fund, at least for this particular financing. Neither lender type is universally better; the right fit depends on which risk profile actually matches your company today, not which one you'd prefer to work with in principle.

Revisit this question at every subsequent financing rather than defaulting back to whichever lender type you used last time. A company that started with a non-bank fund out of necessity two years ago may well have grown into a profile that a bank would now underwrite on more favorable terms, and the only way to find out is to actually ask.

Use these criteria to match lender type to your situation:

• Predictable cash flow, an established banking relationship and a conservative profile point toward a bank lending group, where pricing is more favorable.
• Earlier growth, or no clean fit for bank underwriting, points toward a non-bank fund willing to take on the added risk.
• A tight closing timeline favors a non-bank fund, which can often move through underwriting faster than a bank's credit approval process.
• When comparing term sheets, weigh warrant coverage and covenants alongside rate, since non-bank funds usually price added risk into larger warrants.